Skip to main content

Atopic Dermatitis NEA Approved Features

NEA Approved Features
03/06/2025
Lisa Kuhs, PhD
National Eczema Association survey examines the frequency of acute care needs among patients with atopic dermatitis and the wait times they experience when seeking care from their primary atopic dermatitis health care providers.
National Eczema Association survey examines the frequency of acute care needs among patients with atopic dermatitis and the wait times they experience when seeking care from their primary atopic dermatitis health care providers.
National Eczema Association...
03/06/2025
The Dermatologist
NEA Approved Features
12/02/2024
Jessica Garlewicz
Aligning patient and health care provider definitions can improve communication, treatment effectiveness, and research strategies.
Aligning patient and health care provider definitions can improve communication, treatment effectiveness, and research strategies.
Aligning patient and health care...
12/02/2024
The Dermatologist
NEA Approved Features
09/06/2024
Jessica Garlewicz; Coleen Stern, MA
We know that the mental health burden of having atopic dermatitis is real, but are patients getting the help they need?
We know that the mental health burden of having atopic dermatitis is real, but are patients getting the help they need?
We know that the mental health...
09/06/2024
The Dermatologist
NEA Approved Features
05/03/2024
Jessica Garlewicz
When patients are aware of the connection between their mental health and their eczema symptoms, they may be more likely to seek support.
When patients are aware of the connection between their mental health and their eczema symptoms, they may be more likely to seek support.
When patients are aware of the...
05/03/2024
The Dermatologist
Jeff Yu, MD
Videos
04/29/2022
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how...
04/29/2022
The Dermatologist
NEA Approved Features
03/10/2022
Amanda Balbi
The skin microbiome is complex, and its role in atopic dermatitis disease activity and heterogeneity is still being researched. Dr Peter Lio answered our questions about this association, as well as the ongoing research.
The skin microbiome is complex, and its role in atopic dermatitis disease activity and heterogeneity is still being researched. Dr Peter Lio answered our questions about this association, as well as the ongoing research.
The skin microbiome is complex,...
03/10/2022
The Dermatologist
NEA Approved Features
02/11/2022
Amanda Balbi
The pathophysiology of atopic dermatitis and the risk for COVID-19 is not completely understood. A research team from Yale University conducted a study to close this knowledge gap.
The pathophysiology of atopic dermatitis and the risk for COVID-19 is not completely understood. A research team from Yale University conducted a study to close this knowledge gap.
The pathophysiology of atopic...
02/11/2022
The Dermatologist
NEA Approved Features
12/08/2021
Jessica Garlewicz
A recently published study found that patients with atopic dermatitis treated with dupilumab experienced less severe COVID-19 symptoms compared with other treatments.
A recently published study found that patients with atopic dermatitis treated with dupilumab experienced less severe COVID-19 symptoms compared with other treatments.
A recently published study found...
12/08/2021
The Dermatologist
NEA Approved Features
08/16/2021
Lauren Mateja
Patients with atopic dermatitis and complex treatment regimens are at an increased risk of complications or ill effects, known as iatrogenic burden. Dr Raj Chovatiya explains what dermatologists should know about iatrogenic burden and how to...
Patients with atopic dermatitis and complex treatment regimens are at an increased risk of complications or ill effects, known as iatrogenic burden. Dr Raj Chovatiya explains what dermatologists should know about iatrogenic burden and how to...
Patients with atopic dermatitis...
08/16/2021
The Dermatologist
NEA Approved Features
06/17/2021
Lauren Mateja
As the first advanced therapy approved for atopic dermatitis, dupilumab offers an efficacious option for moderate to severe disease. Dr Amy Paller offers insights on how this biologic can help pediatric patients with eczema and their...
As the first advanced therapy approved for atopic dermatitis, dupilumab offers an efficacious option for moderate to severe disease. Dr Amy Paller offers insights on how this biologic can help pediatric patients with eczema and their...
As the first advanced therapy...
06/17/2021
The Dermatologist